STAT Plus: Pharmalittle: Roche plans aggressive SMA drug pricing; where are those clinical trial results?

Clinical trial reporting rates by most large pharmaceutical companies have improved sharply, but performance by many other trial sponsors, including NIH, was lackluster.

Click to view original post